NCT00547560View on ClinicalTrials.gov

Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population

PHASE1CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Healthy

Interventions

DRUG

GSI-953

Oral capsule, 10- and 50-mg, either once a day for 14 days or twice a day for 14 days, depending on cohort assignment.

Trial Locations (1)

33126

Pfizer Investigational Site, Miami

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00547560 - Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population | Biotech Hunter | Biotech Hunter